全球生命科学软体市场：机会与策略展望（至2034年）

2019 年全球生命科学软体市场规模为 99.377 亿美元，预计到 2024 年将以超过 12.00% 的年复合成长率(CAGR)成长。

生命科学软体是指专为支援和优化生命科学领域（包括製药、生物技术、医疗设备、医疗保健和临床研究）的活动而设计的专用数位解决方案。这类软体用于管理大量复杂的生物学、临床和营运数据，帮助机构改善决策、简化研究流程、确保合规性并改善患者预后。

生命科学软体市场由营业单位（组织、独资企业和伙伴关係）销售的生命科学软体所构成，这些软体由研究人员、科学家、医疗保健提供者、製药公司和监管机构用于药物发现和开发过程中的各个环节，包括临床试验、监管申报、药物安全检测活动、供应链营运和行销职能。

扩大临床试验和外包（CRO）

过去一段时间，临床试验和外包（CRO）的扩张推动了生命科学软体市场的成长。临床试验的扩展以及对CRO（合约委外研发机构）依赖性的增强，正在推动对生命科学软体的需求。这些活动需要先进的解决方案来进行试验管理、数据分析和法规遵循，促使人们广泛采用数位化工具来提高研究效率、准确性和扩充性。例如，根据英国製药工业协会（ABPI）2023年11月发布的报告，2021年临床试验数量为394项，2022年增加至411项。此外，根据总部位于英国的生命科学网路研讨会和虚拟活动提供者Xtalks 2023年5月发布的报告，截至2023年5月17日，ClinicalTrials.gov网站上已註册的临床试验数量为452,604项。在这些已註册的试验中，有64,838项正在积极招募受试者，这意味着2021年註册的试验数量将增加365,000项。因此，临床试验和合约研究组织（CRO）业务的扩张正在推动生命科学软体市场的成长。

利用下一代软体推动生命科学领域的数位转型

生命科学软体市场的企业致力于打造下一代解决方案，以推动数位转型、增强数据集成，并在整个製药和生物技术价值链中实现精准创新。这些企业正利用尖端技术来满足研发和临床领域不断变化的需求。例如，总部位于瑞士的顾问和技术精品公司TenSpin于2025年6月推出了TenSpin Solutions，这是一家专注于为生命科学产业开发创新尖端软体解决方案的技术Start-Ups。这家新公司旨在透过提供以用户为中心、数据驱动的系统来革新该行业，帮助製药、生物技术、医疗技术和动物保健公司在不断变化的数位化环境中进行适应和创新。 TenSpin Solutions专注于深厚的行业专长、卓越的技术能力和出色的用户体验，以支援成长和创新，并透过协同创新模式与生命科学公司紧密合作，精准客製化符合市场需求的解决方案。

全球生命科学软体市场高度分散，众多小型企业在其中运营，到 2024 年，前 10 大竞争对手将占据 24.71% 的市场份额。

目录

第一章执行摘要

• 生命科学软体：市场吸引力与宏观经济状况

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章 市场特征

• 一般市场定义
• 概述
• 生命科学软体市场定义与细分
• 按类型分類的市场细分
  • 预测
  • 说明型
  • 处方类型
• 市场区隔：依部署方式
  • 本地部署
  • 主持人
• 市场区隔：按应用
  • 行销
  • 遵守
  • 研究与开发
  • 药物警戒
  • SCM
• 市场区隔：依最终用户划分
  • 医疗机构
  • 生物製药业
  • 医疗设备业
  • 医学研究中心

第七章：主要市场趋势

• 利用新一代软体推动生命科学领域的数位转型
• 战略生态系统与人工智慧主导平台加速生命科学领域的数位转型
• 新一代人工智慧驱动的数位病理学解决方案，变革研究和诊断
• 策略合作透过先进的云端解决方案变革生命科学领域的参与方式
• 人工智慧驱动的平台重新定义了药物发现和开发。
• 用于简化生物製药计划管理和商业化的下一代云端平台

第八章：全球生命科学软体成长分析及策略分析框架

• 全球生命科学软体的 PESTEL 分析
  • 政治
  • 经济
  • 社会
  • 科技
  • 环境
  • 法律
• 终端用户产业（B2B）分析
  • 医疗机构
  • 生物製药业
  • 医疗设备业
  • 医学研究中心
  • 其他最终用户
• 全球生命科学软体市场：成长率分析
• 市场成长表现（2019-2024）
  • 市场驱动因素（2019-2024）
  • 市场限制（2019-2024）
• 市场成长预测（2024-2029年，2034年）
• 预期成长贡献因素
  • 数量增长的促成因素
  • 司机
  • 抑制因素
• 全球生命科学软体：潜在市场规模 (TAM)

9. 全球生命科学软体市场：细分

• 全球生命科学软体市场按类型、效能和预测划分（2019-2024年、2029年、2034年）
• 全球生命科学软体市场：依部署方式、效能与预测（2019-2024 年、2029 年、2034 年）
• 全球生命科学软体市场：依应用、效能和预测划分（2019-2024年、2029年、2034年）
• 全球生命科学软体市场（依最终用户划分）：绩效与预测（2019-2024年、2029年、2034年）
• 全球生命科学软体市场：细分、预测（按类型）、效能和预测（2019-2024 年、2029 年、2034 年）
• 全球生命科学软体市场：细分、说明（按类型）、效能和预测（2019-2024 年、2029 年、2034 年）
• 全球生命科学软体市场：细分、预测（按类型）、绩效及预测（2019-2024年、2029年、2034年）

第十章：生命科学软体市场：区域与国家分析

• 全球生命科学软体市场：区域表现与预测（2019-2024年、2029年、2034年）
• 全球生命科学软体市场：国家、绩效及预测（2019-2024 年、2029 年、2034 年）

第十一章 亚太市场

第十二章 西欧市场

第十三章 东欧市场

第十四章 北美市场

第十五章：南美市场

第十六章 中东市场

第十七章：非洲市场

第十八章：竞争格局与公司概况

• 公司简介
• Veeva Systems Inc
• IQVIA Holdings Inc
• Microsoft Corporation（Life Sciences）
• Oracle Corporation
• Dassault Systemes SE（Medidata Solution Inc.）

第十九章：其他领先和创新企业

• SAP SE
• UnitedHealth Group Incorporated（Optum Inc.）
• Thermo Fisher Scientific Inc.
• PerkinElmer
• Certara
• Cognizant Technology Solutions Corporation
• Clario
• PAREXEL International Corporation
• DXC Technology Co
• Persistent Systems
• Veradigm（前身为Allscripts Healthcare LLC）
• International Business Machines Corp.
• Fujitsu Ltd.
• ArisGlobal LLC
• LabWare

第二十章：竞争基准化分析

第21章 竞争格局分析

第22章 重大併购

• Instem Acquires Rockstep Solutions To Enhance Digital Platforms For Preclinical Research
• Siemens Expands Life Sciences R&D Capabilities With Dotmatics Acquisition
• Valsoft Enters Life Sciences Sector With Acquisition Of Anju Software

第23章 生命科学软体的最新发展

• 新一代基于代理的人工智慧平台革新生命科学转型
• 面向生命科学的模组化真实世界数据分析平台
• 新平台重新定义生命科学领域的品质和生产控制
• 人工智慧驱动的分析平台变革生命科学领域的数据集成

第24章：机会、策略与潜力分析

• 2029年全球生命科学软体市场：蕴藏新机会的国家
• 2029年全球生命科学软体市场：蕴藏新机会的细分市场
• 2029年全球生命科学软体市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第25章：生命科学软体市场：结论与建议

• 结论
• 建议
  • 产品
  • 分配
  • 价格
  • 促销
  • 人们

第26章附录

Life science software refers to specialized digital solutions designed to support and optimize activities within the life sciences sector, encompassing pharmaceuticals, biotechnology, medical devices, healthcare and clinical research. This software is used to manage vast volumes of complex biological, clinical and operational data, enabling organizations to improve decision-making, streamline research, maintain compliance and enhance patient outcomes.

The life science software market consists of sales, by entities (organizations, sole traders, or partnerships), of life science software that are used by researchers, scientists, healthcare providers, pharmaceutical companies and regulatory bodies. It is employed throughout the drug discovery and development process, in clinical trials, regulatory submissions, pharmacovigilance activities, supply chain operations and marketing functions.

The global life science software market was valued at $9,937.70 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 12.00%.

Expansion Of Clinical Trials And Outsourcing (CROs)

Expansion of clinical trials and outsourcing (CROs) propelled the growth of the life science software market during the historic period. The growth of clinical trials and the rising reliance on contract research organizations (CROs) are fueling demand for life science software. These activities require advanced solutions for trial management, data analysis and regulatory compliance, driving wider adoption of digital tools to enhance efficiency, accuracy and scalability in research. For instance, in November 2023, according to a report published by the Association of the British Pharmaceutical Industry (ABPI), a UK-based association, there were 394 trials in 2021; the clinical trial number increased to 411 in 2022. Additionally, in May 2023, according to Xtalks, a Canada-based company specializing in providing life science webinars and virtual events, there are 452,604 clinical studies that have been registered on ClinicalTrials.gov as of May 17, 2023. 64,838 studies out of the total number that have been registered are actively seeking participants, which is an increase of 365,000 registered trials in 2021. Therefore, expansion of clinical trials and outsourcing (CROs) propelled the growth of the life science software market.

Driving Digital Transformation In Life Sciences Through Next-Generation Software

Companies operating in the life science software market are focusing on creating next-generation solutions that drive digital transformation, enhance data integration and enable precision innovation across the pharmaceutical and biotechnology value chain. These companies are leveraging advanced technologies to address evolving needs in research, development and clinical practices. For instance, in June 2025, Tenthpin, a Switzerland-based boutique consulting and technology company, launched Tenthpin Solutions as a technology start-up dedicated to developing innovative and cutting-edge software solutions for the Life Sciences industry. The new company aims to revolutionize the sector by providing user-centric, data-driven systems that help pharmaceutical, biotech, medical technology and animal health companies adapt and innovate in a transforming digital landscape. Tenthpin Solutions focuses on deep industry expertise, excellent technology skills and superior user experience to support growth and innovation, working closely with Life Sciences companies through co-innovation models to precisely tailor solutions to market needs.

The global life science software market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 24.71% of the total market in 2024.

Life Science Software Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global life science software market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for life science software? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The life science software market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider life science software market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by deployment, by application and by end user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by robot type, by application and by industry in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments- Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for life science software providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Markets Covered:

• 1) By Type: Predictive; Descriptive; Prescriptive
• 2) By Deployment: On-Premises; Hosted
• 3) By Application: Marketing; Compliance; R&D; Pharmacovigilance; SCM
• 4) By End User: Healthcare Institutes; Biopharmaceutical Industry; Medical Devices Industry; Medical Research Centers
• Companies Mentioned: Veeva Systems Inc.; IQVIA Holdings, Inc.; Microsoft (Life Sciences); Oracle Corp.; Dassault Systemes SE (Medidata Solution Inc.)
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; life science software indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Life Science Software - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Life Science Software Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Predictive
  • 6.4.2 Descriptive
  • 6.4.3 Prescriptive
• 6.5 Market Segmentation By Deployment
  • 6.5.1 On-Premises
  • 6.5.2 Hosted
• 6.6 Market Segmentation By Application
  • 6.6.1 Marketing
  • 6.6.2 Compliance
  • 6.6.3 R&D
  • 6.6.4 Pharmacovigilance
  • 6.6.5 SCM
• 6.7 Market Segmentation By End User
  • 6.7.1 Healthcare Institutes
  • 6.7.2 Biopharmaceutical Industry
  • 6.7.3 Medical Devices Industry
  • 6.7.4 Medical Research Centers

7 Major Market Trends

• 7.1 Driving Digital Transformation In Life Sciences Through Next-Generation Software
• 7.2 Strategic Ecosystems And AI-Driven Platforms Accelerate Digital Transformation In Life Sciences
• 7.3 Next-Generation AI-Powered Digital Pathology Solutions Transforming Research And Diagnostics
• 7.4 Strategic Collaboration To Transform Life Sciences Engagement Through Advanced Cloud Solutions
• 7.5 AI-Powered Platform Redefines Drug Discovery And Development
• 7.6 Next-Generation Cloud Platform To Streamline Biopharma Project Management And Commercialization

8 Global Life Science Software Growth Analysis And Strategic Analysis Framework

• 8.1 Global Life Science Software PESTEL Analysis
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 Analysis Of End Use Industries (B2B)
  • 8.2.1 Healthcare Institutes
  • 8.2.2 Biopharmaceutical Industry
  • 8.2.3 Medical Devices Industry
  • 8.2.4 Medical Research Centers
  • 8.2.5 Other End-User
• 8.3 Global Life Science Software Market Growth Rate Analysis
• 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
  • 8.4.1 Market Drivers 2019 - 2024
  • 8.4.1 Market Restraints 2019- 2024
• 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
• 8.6 Forecast Growth Contributors/Factors
  • 8.6.1 Quantitative Growth Contributors
  • 8.6.2 Drivers
  • 8.6.3 Restraints
• 8.7 Global Life Science Software Total Addressable Market (TAM)

9 Global Life Science Software Market Segmentation

• 9.1 Global Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.2 Global Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.3 Global Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.4 Global Life Science Software Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.5 Global Life Science Software Market, Sub-Segmentation Of Predictive, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.6 Global Life Science Software Market, Sub-Segmentation Of Descriptive, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.7 Global Life Science Software Market, Sub-Segmentation Of Prescriptive, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Life Science Software Market, Regional and Country Analysis

• 10.1 Global Life Science Software Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.2 Global Life Science Software Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
• 11.2 Market Overview
  • 11.2.1 Region Information
  • 11.2.2 Market Information
  • 11.2.3 Background Information
  • 11.2.4 Government Initiatives
  • 11.2.5 Regulations
  • 11.2.6 Regulatory Bodies
  • 11.2.7 Major Associations
  • 11.2.8 Taxes Levied
  • 11.2.9 Corporate Tax Structure
  • 11.2.10 Investments
  • 11.2.11 Major Companies
• 11.3 Asia-Pacific Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.4 Asia-Pacific Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.5 Asia-Pacific Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.6 Asia-Pacific Life Science Software Market: Country Analysis
• 11.7 China Market
• 11.8 Summary
• 11.9 Market Overview
  • 11.9.1 Country Information
  • 11.9.2 Market Information
  • 11.9.3 Background Information
  • 11.9.4 Government Initiatives
  • 11.9.5 Regulations
  • 11.9.6 Regulatory Bodies
  • 11.9.7 Major Associations
  • 11.9.8 Taxes Levied
  • 11.9.9 Corporate Tax Structure
  • 11.9.10 Major Companies
• 11.10 China Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.11 China Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.12 China Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.13 India Market
• 11.14 India Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.15 India Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.16 India Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.17 Japan Market
• 11.18 Summary
• 11.19 Market Overview
  • 11.19.1 Country Information
  • 11.19.2 Market Information
  • 11.19.3 Background Information
  • 11.19.4 Government Initiatives
  • 11.19.5 Regulations
  • 11.19.6 Regulatory Bodies
  • 11.19.7 Major Associations
  • 11.19.8 Taxes Levied
  • 11.19.9 Corporate Tax Structure
  • 11.19.10 Investments
  • 11.19.11 Major Companies
• 11.20 Japan Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.21 Japan Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.22 Japan Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.23 Australia Market
• 11.24 Australia Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.25 Australia Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.26 Australia Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.27 Indonesia Market
• 11.28 Indonesia Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.29 Indonesia Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.30 Indonesia Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.31 South Korea Market
• 11.32 Summary
• 11.33 Market Overview
  • 11.33.1 Country Information
  • 11.33.2 Market Information
  • 11.33.3 Background Information
  • 11.33.4 Government Initiatives
  • 11.33.5 Regulations
  • 11.33.6 Regulatory Bodies
  • 11.33.7 Major Associations
  • 11.33.8 Taxes Levied
  • 11.33.9 Corporate Tax Structure
  • 11.33.10 Investments
  • 11.33.11 Major Companies
• 11.34 South Korea Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.35 South Korea Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.36 South Korea Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Western Europe Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.4 Western Europe Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.5 Western Europe Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.6 Western Europe Life Science Software Market: Country Analysis
• 12.7 UK Market
• 12.8 UK Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.9 UK Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.10 UK Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.11 Germany Market
• 12.12 Germany Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.13 Germany Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.14 Germany Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.15 France Market
• 12.16 France Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.17 France Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.18 France Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.19 Italy Market
• 12.20 Italy Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.21 Italy Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.22 Italy Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.23 Spain Market
• 12.24 Spain Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.25 Spain Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.26 Spain Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Major Companies
• 13.3 Eastern Europe Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.4 Eastern Europe Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.5 Eastern Europe Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.6 Eastern Europe Life Science Software Market: Country Analysis
• 13.7 Russia Market
• 13.8 Russia Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.9 Russia Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.10 Russia Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 North America Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.4 North America Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.5 North America Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.6 North America Life Science Software Market: Country Analysis
• 14.7 USA Market
• 14.8 Summary
• 14.9 Market Overview
  • 14.9.1 Country Information
  • 14.9.2 Market Information
  • 14.9.3 Background Information
  • 14.9.4 Government Initiatives
  • 14.9.5 Regulations
  • 14.9.6 Regulatory Bodies
  • 14.9.7 Major Associations
  • 14.9.8 Taxes Levied
  • 14.9.9 Corporate Tax Structure
  • 14.9.10 Investments
  • 14.9.11 Major Companies
• 14.10 USA Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.11 USA Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.12 USA Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.13 Canada Market
• 14.14 Summary
• 14.15 Market Overview
  • 14.15.1 Country Information
  • 14.15.2 Market Information
  • 14.15.3 Background Information
  • 14.15.4 Government Initiatives
  • 14.15.5 Regulations
  • 14.15.6 Regulatory Bodies
  • 14.15.7 Major Associations
  • 14.15.8 Taxes Levied
  • 14.15.9 Corporate Tax Structure
  • 14.15.10 Investments
  • 14.15.11 Major Companies
• 14.16 Canada Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.17 Canada Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.18 Canada Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Major Companies
• 15.3 South America Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.4 South America Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.5 South America Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.6 South America Life Science Software Market: Country Analysis
• 15.7 Brazil Market
• 15.8 Brazil Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.9 Brazil Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.10 Brazil Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Major Companies
• 16.3 Middle East Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.4 Middle East Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.5 Middle East Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Africa Life Science Software Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.4 Africa Life Science Software Market, Segmentation By Deployment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.5 Africa Life Science Software Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Veeva Systems Inc
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Business Strategy
  • 18.2.4 Financial Overview
• 18.3 IQVIA Holdings Inc
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Business Strategy
  • 18.3.4 Financial Overview
• 18.4 Microsoft Corporation (Life Sciences)
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Business Strategy
  • 18.4.4 Financial Overview
• 18.5 Oracle Corporation
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Business Strategy
  • 18.5.4 Financial Overview
• 18.6 Dassault Systemes SE (Medidata Solution Inc.)
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Business Strategy
  • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

• 19.1 SAP SE
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
• 19.2 UnitedHealth Group Incorporated (Optum Inc.)
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
• 19.3 Thermo Fisher Scientific Inc.
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
• 19.4 PerkinElmer
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
• 19.5 Certara
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
• 19.6 Cognizant Technology Solutions Corporation
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
• 19.7 Clario
  • 19.7.1 Company Overview
  • 19.7.2 Products And Services
• 19.8 PAREXEL International Corporation
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
• 19.9 DXC Technology Co
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
• 19.10 Persistent Systems
  • 19.10.1 Company Overview
  • 19.10.2 Products And Services
• 19.11 Veradigm (formerly Allscripts Healthcare LLC)
  • 19.11.1 Company Overview
  • 19.11.2 Products And Services
• 19.12 International Business Machines Corp.
  • 19.12.1 Company Overview
  • 19.12.2 Products And Services
• 19.13 Fujitsu Ltd.
  • 19.13.1 Company Overview
  • 19.13.2 Products And Services
• 19.14 ArisGlobal LLC
  • 19.14.1 Company Overview
  • 19.14.2 Products And Services
• 19.15 LabWare
  • 19.15.1 Company Overview
  • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Instem Acquires Rockstep Solutions To Enhance Digital Platforms For Preclinical Research
• 22.2 Siemens Expands Life Sciences R&D Capabilities With Dotmatics Acquisition
• 22.3 Valsoft Enters Life Sciences Sector With Acquisition Of Anju Software

23 Recent Developments In Life Science Software

• 23.1 Next-Generation Agentic AI Platform Revolutionizes Life Sciences Transformation
• 23.2 A Modular Real-World Data Analytics Platform For Life Sciences
• 23.3 New Platform Redefines Quality And Manufacturing Management In Life Sciences
• 23.4 AI-Powered Analytics Platform Transforms Data Integration In Life Sciences

24 Opportunities And Strategies and Potential Analysis

• 24.1 Global Life Science Software Market In 2029 - Countries Offering Most New Opportunities
• 24.2 Global Life Science Software Market In 2029 - Segments Offering Most New Opportunities
• 24.3 Global Life Science Software Market In 2029 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Life Science Software Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer